I've never been a big advocate or PrEP over other means of HIV prevention. However, if taken properly, the regimen is effective. Adherence is a big "If" here. Regimen maintenance is not high on a lot of people's list & it can lead to issues in prevention.
It shouldn't be surprising, the CDC is recommending the long acting injectable lencapavir, Yeztugo. Gilead's med could be a part of a real game changer in prevention strategy. This article is a clinical abstract on the matter.
It's a new stance by the agency. Give the piece a read. That's all for now.
Cya...
No comments:
Post a Comment